Zhi-Jie Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Recognitions
Zhi-Jie Liu has a total of 616 co-authors. Here are the top co-authors by number of shared publications:
- Neil Shaw
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
24 shared publications - Tian Hua
Human Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
22 shared publications Wei Ding
Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China
17 shared publicationsJunlin Liu
Human Institute, ShanghaiTech University, Shanghai, China
11 shared publications- Suwen Zhao
ShanghaiTech University
11 shared publications Chongyun Cheng
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
10 shared publications
Latest Publications
- 23 October 2026
- Published by Springer Nature in Nature Neuroscience
- p. 1-11
Sustained antidepressant-like effects of psychedelics through 5-HT2AR–β-arrestin signaling
Psychedelics produce long-lasting antidepressant effects, but their hallucinogenic properties limit clinical use. Using structure-guided design of 5-HT2AR–β-arrestin-biased agonists, we identified β-arrestin signaling as a critical driver of prolonged antidepressant-like effects in mice. Here we show that the slow-dissociation kinetics of lysergic acid diethylamide (LSD) enable progressive accumulation of 5-HT2AR engagement during repeated low-dose administration, approaching the receptor occupancy achieved by an acute high dose while avoiding its high peak concentration. This kinetic separation sustains β-arrestin signaling while limiting robust Gαq-mediated Ca2+ responses. Consistent with this framework, repeated low-dose LSD and repeated low-dose psilocybin pretreatment followed by a high-dose psychedelic challenge produced sustained antidepressant-like behavioral effects in mice. In parallel, these regimens produced no detectable psychedelic-associated behavioral disruption in mice and cynomolgus macaques. Together, these findings uncover the signaling basis of sustained psychedelic efficacy and provide a rational framework for developing nonhallucinogenic psychedelic therapies for psychiatric disorders.
- 23 October 2026
- Published by Springer Nature in Nature Neuroscience
- p. 1-11
Sustained antidepressant-like effects of psychedelics through 5-HT2AR–β-arrestin signaling
Psychedelics produce long-lasting antidepressant effects, but their hallucinogenic properties limit clinical use. Using structure-guided design of 5-HT2AR–β-arrestin-biased agonists, we identified β-arrestin signaling as a critical driver of prolonged antidepressant-like effects in mice. Here we show that the slow-dissociation kinetics of lysergic acid diethylamide (LSD) enable progressive accumulation of 5-HT2AR engagement during repeated low-dose administration, approaching the receptor occupancy achieved by an acute high dose while avoiding its high peak concentration. This kinetic separation sustains β-arrestin signaling while limiting robust Gαq-mediated Ca2+ responses. Consistent with this framework, repeated low-dose LSD and repeated low-dose psilocybin pretreatment followed by a high-dose psychedelic challenge produced sustained antidepressant-like behavioral effects in mice. In parallel, these regimens produced no detectable psychedelic-associated behavioral disruption in mice and cynomolgus macaques. Together, these findings uncover the signaling basis of sustained psychedelic efficacy and provide a rational framework for developing nonhallucinogenic psychedelic therapies for psychiatric disorders.
- Open Access
- 17 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9874
Structure-based design of subtype-selective psychedelic analogs
Classical psychedelics exert hallucinogenic and therapeutic effects primarily through activation of serotonin 2 A receptor (5-HT2AR), offering promise as transformative treatments for neuropsychiatric disorders. However, their concurrent activation of 5-HT2BR—associated with cardiac valvulopathy—raises serious safety concerns, underscoring the need for subtype-selective psychedelics. To address this, we determine the cryo-EM structure of 5-HT2AR and perform a comparative structural analysis of the orthosteric binding pockets (OBPs) of 5-HT2AR and 5-HT2BR. Guided by key residue differences, we develop a trigonal pharmacophore model to inform the design of 5-HT2AR-selective agonists that avoid 5-HT2BR activation. Using this model, we design and synthesize two compound series that selectively activate 5-HT2AR while antagonizing 5-HT2BR. Molecular basis of subtype selectivity is confirmed by five additional cryo-EM structures of receptor-ligand complexes. Selected compounds also exhibit antidepressant-like efficacy in animal models. Our findings provide a strategy for the development of safer, subtype-selective psychedelic analogs with therapeutic potential.
- 17 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9874
Open AccessStructure-based design of subtype-selective psychedelic analogs
Classical psychedelics exert hallucinogenic and therapeutic effects primarily through activation of serotonin 2 A receptor (5-HT2AR), offering promise as transformative treatments for neuropsychiatric disorders. However, their concurrent activation of 5-HT2BR—associated with cardiac valvulopathy—raises serious safety concerns, underscoring the need for subtype-selective psychedelics. To address this, we determine the cryo-EM structure of 5-HT2AR and perform a comparative structural analysis of the orthosteric binding pockets (OBPs) of 5-HT2AR and 5-HT2BR. Guided by key residue differences, we develop a trigonal pharmacophore model to inform the design of 5-HT2AR-selective agonists that avoid 5-HT2BR activation. Using this model, we design and synthesize two compound series that selectively activate 5-HT2AR while antagonizing 5-HT2BR. Molecular basis of subtype selectivity is confirmed by five additional cryo-EM structures of receptor-ligand complexes. Selected compounds also exhibit antidepressant-like efficacy in animal models. Our findings provide a strategy for the development of safer, subtype-selective psychedelic analogs with therapeutic potential.
- 24 June 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (7) , 1-13
Structural basis of AtCas9 recognition of PAM mutants in underwound DNA topology
The CRISPR–Cas9 system locates targets through guide RNA pairing and recognition of a protospacer-adjacent motif (PAM). Although PAM specificity is sequence-determined, DNA topology can relax PAM requirements and enable near-PAMless cleavage by the type II-C Alicyclobacillus tengchongensis Cas9 (AtCas9). However, the structural mechanism underlying this regulation remains unknown. Here we report cryogenic-electron microscopy (cryo-EM) structures of AtCas9 bound to B-form DNA or a 340 bp underwound minicircle DNA containing wild-type or mutant PAMs. Despite PAM sequences differences, all three underwound complexes adopt an almost identical architecture distinct from the B-form DNA-bound state. On B-form DNA, AtCas9 recognizes the PAM through base-specific hydrogen bonds and steric exclusion, conferring preference for N4CNNN and N4RNNA (R = A/G). By contrast, underwound DNA widens the PAM major groove and promotes sequence-independent backbone contacts, explaining the near-PAMless cleavage. These findings uncover a topology-dependent mechanism of PAM recognition and establish a cryo-EM platform using underwound minicircle DNA for structural studies under native-like topological states.
- 24 June 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (7) , 1-13
Structural basis of AtCas9 recognition of PAM mutants in underwound DNA topology
The CRISPR–Cas9 system locates targets through guide RNA pairing and recognition of a protospacer-adjacent motif (PAM). Although PAM specificity is sequence-determined, DNA topology can relax PAM requirements and enable near-PAMless cleavage by the type II-C Alicyclobacillus tengchongensis Cas9 (AtCas9). However, the structural mechanism underlying this regulation remains unknown. Here we report cryogenic-electron microscopy (cryo-EM) structures of AtCas9 bound to B-form DNA or a 340 bp underwound minicircle DNA containing wild-type or mutant PAMs. Despite PAM sequences differences, all three underwound complexes adopt an almost identical architecture distinct from the B-form DNA-bound state. On B-form DNA, AtCas9 recognizes the PAM through base-specific hydrogen bonds and steric exclusion, conferring preference for N4CNNN and N4RNNA (R = A/G). By contrast, underwound DNA widens the PAM major groove and promotes sequence-independent backbone contacts, explaining the near-PAMless cleavage. These findings uncover a topology-dependent mechanism of PAM recognition and establish a cryo-EM platform using underwound minicircle DNA for structural studies under native-like topological states.
- 19 June 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (8) , 1942-1953
Tryptamine from wake-active monoaminergic neurons regulates sleep homeostasis
Wakefulness produces sleep-promoting substances and the cerebrospinal fluid contains substances that reflect homeostatic sleep pressure. However, identities of such molecules, and the neural mechanisms for producing and sensing them, remain mysterious. Here we show that cerebrospinal fluid levels of tryptamine (TrpA) track homeostatic sleep pressure in nocturnal mice and diurnal pigs, reflecting physical activity history independently of light-dark cycles. We developed a ratiometric fluorescent sensor for TrpA and showed that TrpA is produced by wake-active monoaminergic nuclei in the diencephalon and brainstem and is secreted in an activity-dependent manner. We showed that released TrpA binds to G-protein-coupled receptor 139 (GPR139) and enhances neuronal excitability in the hypothalamic preoptic area to promote sleep. TrpA-GPR139 signaling was necessary for homeostatic sleep rebound and small-molecule GPR139 agonists promoted sleep duration and quality. Together, our study reveals TrpA as a signal related to sleep homeostasis and GPR139 as a druggable target against its disruption.
- 19 June 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (8) , 1942-1953
Tryptamine from wake-active monoaminergic neurons regulates sleep homeostasis
Wakefulness produces sleep-promoting substances and the cerebrospinal fluid contains substances that reflect homeostatic sleep pressure. However, identities of such molecules, and the neural mechanisms for producing and sensing them, remain mysterious. Here we show that cerebrospinal fluid levels of tryptamine (TrpA) track homeostatic sleep pressure in nocturnal mice and diurnal pigs, reflecting physical activity history independently of light-dark cycles. We developed a ratiometric fluorescent sensor for TrpA and showed that TrpA is produced by wake-active monoaminergic nuclei in the diencephalon and brainstem and is secreted in an activity-dependent manner. We showed that released TrpA binds to G-protein-coupled receptor 139 (GPR139) and enhances neuronal excitability in the hypothalamic preoptic area to promote sleep. TrpA-GPR139 signaling was necessary for homeostatic sleep rebound and small-molecule GPR139 agonists promoted sleep duration and quality. Together, our study reveals TrpA as a signal related to sleep homeostasis and GPR139 as a druggable target against its disruption.
- Open Access
Cryo-EM as latent structural landscape microscopy
A protein populates a landscape of structural states, abundant snapshots of which are sampled in every cryo-EM experiment. Current analysis averages these snapshots into single density maps or partitions them into discrete classes, discarding the continuous dynamics encoded in the data. Continuous latent-space methods offer a promising alternative, yet whether their learned representations are physically grounded remains unresolved. Here, we realize cryo-EM as structural landscape microscopy, in which latent density directly reflects the probabilistic distribution of molecular states. A central question is whether such a landscape reflects physical reality. For integrin αvβ 8 , the learned landscape shows strong agreement with independently derived molecular dynamics simulations, supporting its physical plausibility. We then apply the landscape to structural states that conventional cryo-EM cannot resolve. For LIS1-mediated dynein activation, the landscape reveals a spectrum of states from dominant conformations to low-population intermediates defined by distinct binding modes, including a previously unresolved state. For the KCTD5/CUL3 NTD /G βγ complex, the landscape resolves continuous conformational pathways directly from experimental data. Probability-guided particle selection further improves reconstruction quality.
Open AccessCryo-EM as latent structural landscape microscopy
A protein populates a landscape of structural states, abundant snapshots of which are sampled in every cryo-EM experiment. Current analysis averages these snapshots into single density maps or partitions them into discrete classes, discarding the continuous dynamics encoded in the data. Continuous latent-space methods offer a promising alternative, yet whether their learned representations are physically grounded remains unresolved. Here, we realize cryo-EM as structural landscape microscopy, in which latent density directly reflects the probabilistic distribution of molecular states. A central question is whether such a landscape reflects physical reality. For integrin αvβ 8 , the learned landscape shows strong agreement with independently derived molecular dynamics simulations, supporting its physical plausibility. We then apply the landscape to structural states that conventional cryo-EM cannot resolve. For LIS1-mediated dynein activation, the landscape reveals a spectrum of states from dominant conformations to low-population intermediates defined by distinct binding modes, including a previously unresolved state. For the KCTD5/CUL3 NTD /G βγ complex, the landscape resolves continuous conformational pathways directly from experimental data. Probability-guided particle selection further improves reconstruction quality.
- Top Cited Papers
Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2
- Open Access
- 9 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
The orphan G protein-coupled receptor (GPCR) GPR139 attracts interest as a target for neuropsychiatric disorders. Whereas the physiological functions of GPR139 remain elusive, a high-resolution receptor structure is now available. To assess whether structural information enables ligand discovery, we computationally dock 235 million compounds to the GPR139 binding site. Of 68 top-ranked compounds evaluated experimentally, five are full agonists with potencies ranging from 160 nM to 3.6 µM. Structure-guided optimization identifies one of the most potent GPR139 agonists, and a cryo-EM structure of the receptor-ligand complex confirms the predicted binding mode. Functional characterization provides insights into GPR139 signalling, and one agonist elicits behavioural effects in mice. We also explore the potential to replace experimental structure determination with the deep-learning method AlphaFold3, revealing a limited capability of artificial intelligence to model receptor-ligand interactions for understudied GPCRs. The results demonstrate how high-resolution GPCR structures combined with large-library docking can accelerate drug discovery.
- 9 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessUltra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
The orphan G protein-coupled receptor (GPCR) GPR139 attracts interest as a target for neuropsychiatric disorders. Whereas the physiological functions of GPR139 remain elusive, a high-resolution receptor structure is now available. To assess whether structural information enables ligand discovery, we computationally dock 235 million compounds to the GPR139 binding site. Of 68 top-ranked compounds evaluated experimentally, five are full agonists with potencies ranging from 160 nM to 3.6 µM. Structure-guided optimization identifies one of the most potent GPR139 agonists, and a cryo-EM structure of the receptor-ligand complex confirms the predicted binding mode. Functional characterization provides insights into GPR139 signalling, and one agonist elicits behavioural effects in mice. We also explore the potential to replace experimental structure determination with the deep-learning method AlphaFold3, revealing a limited capability of artificial intelligence to model receptor-ligand interactions for understudied GPCRs. The results demonstrate how high-resolution GPCR structures combined with large-library docking can accelerate drug discovery.
- RetractionOpen Access
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 645 (8080) , 544
Retraction Note: Crystal structures of agonist-bound human cannabinoid receptor CB1
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 645 (8080) , 544
RetractionOpen AccessRetraction Note: Crystal structures of agonist-bound human cannabinoid receptor CB1
- Retracted
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8085) , 754-758
Crystal structures of agonist-bound human cannabinoid receptor CB1
Cannabinoid receptor 1 (CB1) is the primary target of the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC), the psychoactive constituent of marijuana1. Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB1–agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state2, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe2003.36 and Trp3566.48 (where the superscripts denote Ballesteros–Weinstein numbering3) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8085) , 754-758
RetractedCrystal structures of agonist-bound human cannabinoid receptor CB1
Cannabinoid receptor 1 (CB1) is the primary target of the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC), the psychoactive constituent of marijuana1. Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB1–agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state2, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe2003.36 and Trp3566.48 (where the superscripts denote Ballesteros–Weinstein numbering3) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
- Top Cited Papers
- 24 June 2025
- Published by Springer Nature in Nature
- Vol. 645 (8081) , 801-808
Structural and functional characterization of human sweet taste receptor
Sweet taste perception influences dietary choices and metabolic health. The human sweet taste receptor, a class C G protein-coupled receptor (GPCR) heterodimer composed of TAS1R2-TAS1R31,2, senses a wide range of sweet compounds — including natural sugars, artificial sweeteners and sweet proteins — impacting metabolic regulation beyond taste. However, the lack of three-dimensional structures hinders our understanding of its precise working mechanism. Here, we present cryo-EM structures of the full-length human sweet taste receptor in apo- and sucralose-bound states. These structures reveal a distinct asymmetric heterodimer architecture, with sucralose binding exclusively to the Venus flytrap domain of TAS1R2. Combining mutagenesis and molecular dynamics simulations, this work delineates the sweeteners recognition modes in TAS1R2. Structural comparisons further uncover the conformational changes upon ligand binding and unique activation mechanism. These findings illuminate the signal transduction mechanisms of chemosensory receptors in class C GPCRs and provide molecular basis for new-generation sweetener design.
- 24 June 2025
- Published by Springer Nature in Nature
- Vol. 645 (8081) , 801-808
Top Cited PapersStructural and functional characterization of human sweet taste receptor
Sweet taste perception influences dietary choices and metabolic health. The human sweet taste receptor, a class C G protein-coupled receptor (GPCR) heterodimer composed of TAS1R2-TAS1R31,2, senses a wide range of sweet compounds — including natural sugars, artificial sweeteners and sweet proteins — impacting metabolic regulation beyond taste. However, the lack of three-dimensional structures hinders our understanding of its precise working mechanism. Here, we present cryo-EM structures of the full-length human sweet taste receptor in apo- and sucralose-bound states. These structures reveal a distinct asymmetric heterodimer architecture, with sucralose binding exclusively to the Venus flytrap domain of TAS1R2. Combining mutagenesis and molecular dynamics simulations, this work delineates the sweeteners recognition modes in TAS1R2. Structural comparisons further uncover the conformational changes upon ligand binding and unique activation mechanism. These findings illuminate the signal transduction mechanisms of chemosensory receptors in class C GPCRs and provide molecular basis for new-generation sweetener design.